home / stock / kod / kod news


KOD News and Press, Kodiak Sciences Inc From 09/25/25

Stock Information

Company Name: Kodiak Sciences Inc
Stock Symbol: KOD
Market: NASDAQ
Website: kodiak.com

Menu

KOD KOD Quote KOD Short KOD News KOD Articles KOD Message Board
Get KOD Alerts

News, Short Squeeze, Breakout and More Instantly...

KOD - Kodiak Sciences Inc. (NASDAQ: KOD) Rises Sharply in 9/25 Early Trading Session

2025-09-25 11:06:59 ET Kodiak Sciences Inc. (NASDAQ: KOD) is one of today’s top gainers. The company’s shares have moved 19.82% on the day to $18.56. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics...

KOD - Kodiak gains as Barclays upgrades on Roche data for eye disease drug

2025-09-25 10:35:17 ET More on Kodiak Sciences Kodiak Sciences: Odds May Be Narrowing For Longer Lasting Eye Disease Med Approval Seeking Alpha’s Quant Rating on Kodiak Sciences Historical earnings data for Kodiak Sciences Financial information for Kod...

KOD - US Companies Moving the Markets, Evening edition
Mon, Sep 22, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 3.9% to $183.61 on volume of 266,943,783 shares Oriental Rise Holdings Limited (ORIS) rose 43.8% to $0.228 on volume of 257,217,826 shares Opendoor Technologies Inc (OPEN) fell 12.4% to $8.38 on volume of ...

KOD - Tracking Baker Brothers Portfolio - Q2 2025 Update

2025-09-15 20:21:09 ET This article is part of a series that provides an ongoing analysis of the changes made to Baker Brothers’ 13F stock portfolio on a quarterly basis. It is based on Baker Brothers’ regulatory 13F Form filed on 08/14/2025. The 13F portfolio value in...

KOD - New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)

New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI) PR Newswire Meaningful vision gains are rapidly achieved as early as week 4 and more than half of patie...

KOD - Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI)

Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI) PR Newswire PALO ALTO, Calif. , Sept. 2, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precomm...

KOD - Kodiak Sciences GAAP EPS of -$1.03 beats by $0.02

2025-08-13 16:30:04 ET More on Kodiak Sciences Seeking Alpha’s Quant Rating on Kodiak Sciences Historical earnings data for Kodiak Sciences Financial information for Kodiak Sciences Read the full article on Seeking Alpha For further details see...

KOD - Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2025 Financial Results PR Newswire PALO ALTO, Calif. , Aug. 13, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for th...

KOD - Expected US Company Earnings on Wednesday, August 13th, 2025

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...

KOD - Expected earnings - Kodiak Sciences Inc

Kodiak Sciences Inc (KOD) is expected to report $-1.01 for Q2 2025

Previous 10 Next 10